USANA Health Sciences Q4 EPS Surges 46%, Revenue Tops $226.2 Million
USANA posted Q4 adjusted EPS of $0.60, beating the $0.41 consensus by 46.3% while dropping from $0.64 a year earlier. Revenue reached $226.2 million, exceeding estimates by 0.11% and up from $213.6 million.
1. Q4 Earnings Beat Expectations
USANA delivered adjusted earnings of $0.60 per share for the quarter ended December 2025, topping the $0.41 consensus estimate by 46.3%. This result compares with $0.64 per share in the same quarter a year ago, marking three beats in the last four quarters.
2. Revenue Growth and Year-Over-Year Comparison
The company recorded revenues of $226.2 million, surpassing forecasts by 0.11% and rising 6.0% from $213.6 million a year earlier. Consistent upside versus expectations has occurred in three of the past four quarters.
3. Estimate Revisions and Forward Outlook
Consensus for the upcoming quarter stands at $0.40 in EPS on $237.6 million in revenue, with full-year projections of $1.84 in EPS and $956.2 million in revenue. Trends in analyst estimate revisions and management commentary on the earnings call will likely dictate near-term stock movement.